查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618274

呼吸气体监测仪:市场洞察·竞争环境·市场预测 (～2030年)

Respiratory Gas Monitors - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

气喘、慢性阻塞性肺病和肺炎等呼吸系统疾病的盛行率不断上升，推动了医院和家庭护理机构对持续呼吸监测的需求。此外，全球外科手术的增加增加了对准确麻醉监测的需求，而呼吸气体监测仪在追踪氧气和二氧化碳水平以确保患者安全方面发挥关键作用。由于对有效麻醉护理的需求不断增加和技术进步，市场领导者正在推出更多产品并获得监管部门的批准。这些具有无线连接和即时数据分析等增强功能的新设备透过满足医疗保健提供者和患者不断变化的需求，进一步推动了市场成长。这些因素结合在一起，预计将在 2024 年至 2030 年的预测期内推动呼吸气体监测仪市场的发展。

呼吸气体监测仪：市场动态

根据澳洲健康与福利研究所的最新数据，预计2022年澳洲约有850万人（34%）患有慢性呼吸道疾病。

此外，根据《全球疾病负担》（2023 年）的最新数据，世界上大约每 20 人中就有 1 人患有慢性呼吸道疾病。

此外，根据世界卫生组织 (2024) 提供的最新数据和统计数据，气喘影响全球估计 2.62 亿人。气喘、慢性阻塞性肺病 (COPD) 和肺部感染等呼吸系统疾病的增加极大地推动了呼吸气体监测仪市场的发展。随着越来越多的患者需要持续监测氧气、二氧化碳和其他呼吸气体，医院和诊所正在采用先进的监测系统来提供更好的护理。这些设备可以帮助检测呼吸窘迫的早期迹象，优化治疗计划并改善患者的治疗结果。慢性呼吸道疾病的增加也增加了对医疗机构和家庭长期监测的需求，进一步增加了对便携式、非侵入性呼吸气体监测仪的需求。

按设备划分，脉搏血氧计预计将在 2023 年占据重要的市场占有率。脉搏血氧仪为监测患者血氧饱和度 (SpO2) 和心率提供经济高效的非侵入性解决方案，对整个呼吸气体监测仪市场产生重大影响。医院、门诊诊所和家庭护理等各种医疗机构的广泛采用正在推动对呼吸监测解决方案的需求。脉搏血氧计的易用性和快速提供的结果使其成为医疗保健提供者的重要工具，特别是在管理慢性阻塞性肺病 (COPD) 和哮喘等呼吸系统疾病患者以及外科手术期间。

本报告提供全球呼吸气体监测仪的市场调查，彙整市场概要，市场影响因素及市场机会分析，法律制度，市场规模的转变·预测，各种区分·地区/各主要国家的详细分析，竞争情形，主要企业简介等资讯。

目录

第1章 呼吸气体监测仪市场报告:简介

  • 调查范围
  • 市场分类
  • 市场估计

第2章 呼吸气体监测仪市场:摘要整理

  • 市场概要

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 呼吸气体监测仪市场:主要要素分析

  • 推动市场要素
    • 呼吸道疾病的发生率增加
    • 世界各地的外科手术数量不断增加。
    • 麻醉监测需求不断增加
  • 市场限制与挑战
    • 产品召回次数增加
    • 有关产品核准的严格监理问题
  • 市场机会
    • 将人工智慧和远距医疗服务整合到呼吸气体监测仪中

第6章 呼吸气体监测仪市场:波特的五力分析

第7章 呼吸气体监测仪市场评估

  • 各设备
    • 二氧化碳测量仪
    • 脉动式血氧监测仪系统
    • 肺计量计
    • 其他
  • 各终端用户
    • 医院
    • 诊所
    • 门诊病人手术中心
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 呼吸气体监测仪市场:企业·产品简介

  • Medtronic plc.
  • Koninklijke Philips N.V.
  • Nihon Kohden Corporation
  • Dragerwerk AG & Co. KGaA
  • Stryker
  • GE Healthcare
  • ndd Medical Technologies
  • VYAIRE
  • Baxter
  • Contec
  • Zoll Medical Corporation
  • ICU Medical
  • Hamilton Medical
  • Avante Health Solutions
  • Nonin
  • BD
  • EDAN Instruments, Inc.
  • Criticare Technologies, Inc.
  • HILLROM
  • Masimo

第9章 KOL的见解

第10章 计划的方法

第11章 关于DelveInsight

第12章 免责声明·联络方式

Product Code: DIMDCL0015

Respiratory Gas Monitors Market by Device (Capnographs, Pulse Oximeters, Spirometers, and Others), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of respiratory disorders, increasing number of surgical procedures across the globe, and growing demand for anesthesia monitoring.

The global respiratory gas monitors market was valued at USD XX million in 2023, growing at a CAGR of XX% during the forecast period from 2024 to 2030 to reach USD XX million by 2030. The rising prevalence of respiratory disorders, such as asthma, COPD, and pneumonia, is driving the demand for continuous respiratory monitoring in hospitals and homecare settings. Additionally, the increasing number of surgical procedures worldwide has heightened the need for precise anesthesia monitoring, where respiratory gas monitors play a critical role in tracking oxygen and CO2 levels to ensure patient safety. The growing demand for effective anesthesia care and rising advancements in technology, leading to more product launches and regulatory approvals by key players in the market. These new devices, equipped with enhanced features like wireless connectivity and real-time data analysis, further fuel market growth by meeting the evolving needs of healthcare providers and patients globally. Together, these factors are expected to boost the market of respiratory gas monitors during the forecast period from 2024 to 2030.

Respiratory Gas Monitors Market Dynamics:

According to the latest data provided by the Australian Institute of Health and Welfare, in 2022, around 8.5 million (34%) people in Australia were estimated to have chronic respiratory conditions.

Additionally, as per the recent data provided by the Global Burden of Disease (2023), approximately, 1 in 20 people globally suffered from chronic respiratory diseases.

Furthermore, according to the recent data and stats provided by World Health Organization (2024), asthma affected an estimated 262 million people globally. The increase in respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), lung infections is significantly driving the market for respiratory gas monitors. With a growing number of patients requiring continuous monitoring of oxygen, carbon dioxide, and other respiratory gases, hospitals and clinics are adopting advanced monitoring systems to provide better care. These devices help detect early signs of respiratory distress, optimize treatment plans, and improve patient outcomes. The rise in chronic respiratory conditions also increases the need for long-term monitoring, both in healthcare facilities and at home, further boosting the demand for portable and non-invasive respiratory gas monitors.

According to the Global Surgery Foundation 2021 reports, about 30% of the global burden of disease is caused by conditions that can be treated by surgery. The increase in surgical procedures globally is driving the demand for respiratory gas monitors, as these devices play a vital role in patient safety during anesthesia administration. Accurate monitoring of gases like oxygen, carbon dioxide, and anesthetic agents is crucial to ensure proper ventilation and prevent complications such as hypoxia or hypercapnia. As the number of surgeries rises-particularly in areas such as cardiovascular, orthopedic, and bariatric procedures-the need for advanced anesthesia monitoring systems grows and thus the demand for respiratory gas monitors esclates. Additionally, complex surgeries often require prolonged anesthesia, making continuous respiratory monitoring essential in both operating rooms and post-anesthesia care units (PACUs). Thus, the adoption of respiratory gas monitors is further bolstered by the rise in number of surgical procedures, where real-time gas monitoring supports quicker patient recovery and discharge.

Thus, the factors mentioned above are likely to boost the market of respiratory gas monitors during the forecasted period.

However, the increased product recalls for respiratory gas monitors and stringent regulatory concerns for product approval may hinder the future market of respiratory gas monitors.

Respiratory Gas Monitors Market Segment Analysis:

Respiratory Gas Monitors Market by Device (Capnographs, Pulse Oximeters, Spirometers, and Others), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device segment of the respiratory gas monitors market, pulse oximeters are projected to hold a considerable market share in 2023. Pulse oximeters have significantly influenced the overall market of respiratory gas monitors by providing a cost-effective, non-invasive solution for monitoring patients' oxygen saturation levels (SpO2) and heart rates. Their widespread adoption across various healthcare settings, including hospitals, outpatient clinics, and home care, has driven demand for respiratory monitoring solutions. The ease of use and rapid results offered by pulse oximeters make them an essential tool for healthcare providers, especially in the management of patients with respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and during surgical procedures.

Additionally, the increasing prevalence of respiratory illnesses, coupled with the rising emphasis on remote patient monitoring and telehealth services, has propelled the demand for pulse oximeters, leading to enhanced integration with other respiratory monitoring systems. For instance, as per the recent data provided by the World Health Organization (2023), smoking was a major cause of chronic obstructive pulmonary disease, a common lung condition that led to breathing difficulties and claimed over 3 million lives annually. Approximately 392 million people had COPD, with about 75% living in low- and middle-income countries. In high-income countries, tobacco smoking was responsible for over 70% of COPD cases. Patients with COPD often experience hypoxemia (low blood oxygen levels), necessitating continuous monitoring to ensure appropriate oxygen therapy and prevent exacerbations. Pulse oximeters provide a non-invasive, rapid, and accurate means to assess oxygen saturation levels in patients, enabling healthcare providers to make timely decisions regarding treatment adjustments.

Additionally, the increasing product approval across the globe are further propelling the market of the segment. In February 2024, Masimo announced FDA clearance of MightySat(R) Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available Over-The-Counter (OTC) direct to consumers without a prescription.

Therefore, owing to the above-mentioned factors, the pulse oximeter category is expected to generate considerable revenue thereby pushing the overall growth of the global respiratory gas monitors market during the forecast period.

North America is expected to dominate the overall respiratory gas monitors market:

Among all the regions, North America is expected to hold the largest share in the global Respiratory Gas Monitors market in 2023. The rising prevalence of respiratory disorders, such as asthma and Chronic Obstructive Pulmonary Disease (COPD), is driving the need for effective monitoring solutions to manage these conditions. Additionally, the growing number of surgical procedures and the heightened focus on patient safety and anesthesia management further contribute to market growth. Furthermore, significant investments in research and development by leading medical device companies in North America are resulting in innovative product launches and technological advancements, enhancing the efficacy and usability of respiratory gas monitors.

According to the recent data and stats provided by American Lung Association (2024), asthma accounted for 10.8% for females and 6.5% for males across the region of United States. Additionally, as per the data provided by the Centre for Disease Control and Prevention (2024), in 2022, 4.6% of adults had been diagnosed with COPD, emphysema, or chronic bronchitis in the United States. COPD, characterized by airflow limitation and respiratory symptoms, often leads to hypoxemia, requiring continuous oxygen saturation monitoring to adjust therapies appropriately. Similarly, asthma patients face variable airflow obstruction, which can lead to acute episodes, making real-time monitoring of respiratory gases essential for timely interventions. Therefore, the rising prevalence of Chronic Obstructive Pulmonary Disease (COPD) and asthma is significantly boosting the market for respiratory gas monitors, as these conditions necessitate effective monitoring and management to ensure optimal patient outcomes.

Furthermore, the increasing number of product development activities in the region is further going to accelerate the growth of the respiratory gas monitors market. For instance, in August 2021, Roundworks Technologies Private Limited announced the approval of 510(k) for its alveoair Digital Spirometer. alveoair(R) is a personal spirometer designed for asthma, COPD, cystic fibrosis and ILD patients to help quantify their lung health.

Therefore, the factors mentioned above are expected to boost the growth of the respiratory gas monitors market in the North America region during the forecast period from 2024 to 2030.

Respiratory Gas Monitors Market Key Players:

Some of the key market players operating in the respiratory gas monitors market include Medtronic plc., Koninklijke Philips N.V., Nihon Kohden Corporation, Dragerwerk AG & Co. KGaA, Stryker, GE Healthcare, ndd Medical Technologies, VYAIRE, Baxter, Contec, Zoll Medical Corporation, ICU Medical, Hamilton Medical, Avante Health Solutions, Nonin, BD, EDAN Instruments, Inc., Criticare Technologies, Inc., and HILLROM, and others.

Recent Developmental Activities in the Respiratory Gas Monitors Market:

  • In January, 2024, NuvoAir Medical announced that its innovative Air Next Spirometer had received formal 510(k) clearance for in-home use as a full spirometer.
  • In September 2022, RxCap, Inc., a cloud-based remote monitoring company, and ZEPHYRx LLC, a provider of remote respiratory monitoring solutions, announced their partnership to integrate ZEPHYRx's cloud spirometry platform with RxCap's remote monitoring platform.
  • In March 2022, KoKo, LLC, a software developer and medical device manufacturer and MAGNET group, a purchasing organizations (GPO) company signed a three-year partnership contract that allows access to all KoKo's "gold standard" lung function diagnostics and software for spirometry, diffusion capacity, and PFT.
  • In June 2021, DetelPro launched the Oxy10 pulse oximeter. This compact device has an LED display which can easily be attached to the fingertip, providing readings for oxygen saturation and pulse rate.

Key Takeaways From the Respiratory Gas Monitors Market Report Study:

  • Market size analysis for current respiratory gas monitors size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the respiratory gas monitors market.
  • Various opportunities available for the other competitors in the respiratory gas monitors market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current respiratory gas monitors market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for respiratory gas monitors market growth in the coming future?

Target Audience who can be Benefited From This Respiratory Gas Monitors Market Report Study:

  • Respiratory gas monitors product providers
  • Research organizations and consulting companies
  • Respiratory gas monitors-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in respiratory gas monitors
  • Various end-users who want to know more about the respiratory gas monitors market and the latest technological developments in the respiratory gas monitors market.

Frequently Asked Questions for the Respiratory Gas Monitors Market:

1. What are respiratory gas monitors?

  • Respiratory Gas Monitors are medical devices that measure oxygen and carbon dioxide levels in a patient's respiratory system, vital for ventilation and oxygenation in critical care.

2. What is the market for respiratory gas monitors?

  • The global respiratory gas monitors market was valued at USD XX million in 2023, growing at a CAGR of XX% during the forecast period from 2024 to 2030 to reach USD XX million by 2030.

3. What are the drivers for the respiratory gas monitors market?

  • The rising prevalence of respiratory disorders, such as asthma, COPD, and pneumonia, is driving the demand for continuous respiratory monitoring in hospitals and homecare settings. Additionally, the increasing number of surgical procedures worldwide has heightened the need for precise anesthesia monitoring, where respiratory gas monitors play a critical role in tracking oxygen and CO2 levels to ensure patient safety. The growing demand for effective anesthesia care aligns with advancements in technology, leading to more product launches and regulatory approvals by key players in the market. These new devices, equipped with enhanced features like wireless connectivity and real-time data analysis, further fuel market growth by meeting the evolving needs of healthcare providers and patients globally. Together, these factors are expected to boost the market of respiratory gas monitors during the forecast period from 2024 to 2030.

4. Who are the key players operating in the respiratory gas monitors market?

  • Some of the key market players operating in the Respiratory Gas Monitors market include Medtronic plc., Koninklijke Philips N.V., Nihon Kohden Corporation, Dragerwerk AG & Co. KGaA, Stryker, GE Healthcare, ndd Medical Technologies, VYAIRE, Baxter, Contec, Zoll Medical Corporation, ICU Medical, Hamilton Medical, Avante Health Solutions, Nonin, BD, EDAN Instruments, Inc., Criticare Technologies, Inc., and HILLROM, Masimo, and others.

5. Which region has the highest share in the respiratory gas monitors market?

  • Among all the regions, North America is expected to hold the largest share in the global Respiratory Gas Monitors market in 2023. The rising prevalence of respiratory disorders, such as asthma and Chronic Obstructive Pulmonary Disease (COPD), is driving the need for effective monitoring solutions to manage these conditions. Additionally, the growing number of surgical procedures and the heightened focus on patient safety and anesthesia management further contribute to market growth. Furthermore, significant investments in research and development by leading medical device companies in North America are resulting in innovative product launches and technological advancements, enhancing the efficacy and usability of respiratory gas monitors.

Table of Contents

1. Respiratory Gas Monitors Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Respiratory Gas Monitors Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Respiratory Gas Monitors Market Key Factors Analysis

  • 5.1. Respiratory Gas Monitors Market Drivers
    • 5.1.1. Rising prevalence of respiratory disorders
    • 5.1.2. Increasing number of surgical procedures across the globe
    • 5.1.3. Increased demand for anesthesia monitoring
  • 5.2. Respiratory Gas Monitors Market Restraints and Challenges
    • 5.2.1. Increased product recalls
    • 5.2.2. Stringent regulatory concerns for product approval
  • 5.3. Respiratory Gas Monitors Market Opportunities
    • 5.3.1. Integration of artificial intelligence and telehealth services in respiratory gas monitors

6. Respiratory Gas Monitors Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Respiratory Gas Monitors Market Assessment

  • 7.1. By Device
    • 7.1.1. Capnographs
    • 7.1.2. Pulse Oximeters
    • 7.1.3. Spirometers
    • 7.1.4. Others
  • 7.2. By End User
    • 7.2.1. Hospitals
    • 7.2.2. Clinics
    • 7.2.3. Ambulatory Surgical Centers
    • 7.2.4. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.1.2. Canada Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.1.3. Mexico Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.2.2. Germany Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.2.3. United Kingdom Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.2.4. Italy Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.2.5. Spain Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.2.6. Rest of Europe Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.3.2. Japan Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.3.3. India Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.3.4. Australia Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.3.5. South Korea Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.4.2. Africa Respiratory Gas Monitors Market Size in USD Million (2021-2030)
      • 7.3.4.3. South America Respiratory Gas Monitors Market Size in USD Million (2021-2030)

8. Respiratory Gas Monitors Market Company and Product Profiles

  • 8.1. Medtronic plc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Koninklijke Philips N.V.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Nihon Kohden Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Dragerwerk AG & Co. KGaA
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Stryker
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. GE Healthcare
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. ndd Medical Technologies
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. VYAIRE
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Baxter
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Contec
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Zoll Medical Corporation
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. ICU Medical
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Hamilton Medical
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Avante Health Solutions
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Nonin
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. BD
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. EDAN Instruments, Inc.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Criticare Technologies, Inc.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. HILLROM
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Masimo
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Respiratory Gas Monitors Market in Global (2021-2030)
  • Table 3: Respiratory Gas Monitors Market in Global by Device (2021-2030)
  • Table 4: Respiratory Gas Monitors Market in Global by End-User (2021-2030)
  • Table 5: Respiratory Gas Monitors Market in Global by Geography (2021-2030)
  • Table 6: Respiratory Gas Monitors Market in North America (2021-2030)
  • Table 7: Respiratory Gas Monitors Market in the United States (2021-2030)
  • Table 8: Respiratory Gas Monitors Market in Canada (2021-2030)
  • Table 9: Respiratory Gas Monitors Market in Mexico (2021-2030)
  • Table 10: Respiratory Gas Monitors Market in Europe (2021-2030)
  • Table 11: Respiratory Gas Monitors Market in France (2021-2030)
  • Table 12: Respiratory Gas Monitors Market in Germany (2021-2030)
  • Table 13: Respiratory Gas Monitors Market in United Kingdom (2021-2030)
  • Table 14: Respiratory Gas Monitors Market in Italy (2021-2030)
  • Table 15: Respiratory Gas Monitors Market in Spain (2021-2030)
  • Table 16: Respiratory Gas Monitors Market in the Rest of Europe (2021-2030)
  • Table 17: Respiratory Gas Monitors Market in Asia-Pacific (2021-2030)
  • Table 18: Respiratory Gas Monitors Market in China (2021-2030)
  • Table 19: Respiratory Gas Monitors Market in Japan (2021-2030)
  • Table 20: Respiratory Gas Monitors Market in India (2021-2030)
  • Table 21: Respiratory Gas Monitors Market in Australia (2021-2030)
  • Table 22: Respiratory Gas Monitors Market in South Korea (2021-2030)
  • Table 23: Respiratory Gas Monitors Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Respiratory Gas Monitors Market in the Rest of the World (2021-2030)
  • Table 25: Respiratory Gas Monitors Market in the Middle East (2021-2030)
  • Table 26: Respiratory Gas Monitors Market in Africa (2021-2030)
  • Table 27: Respiratory Gas Monitors Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Respiratory Gas Monitors Market in Global (2021-2030)
  • Figure 3: Respiratory Gas Monitors Market in Global by Device (2021-2030)
  • Figure 4: Respiratory Gas Monitors Market in Global by End-User (2021-2030)
  • Figure 5: Respiratory Gas Monitors Market in Global by Geography (2021-2030)
  • Figure 6: Respiratory Gas Monitors Market in North America (2021-2030)
  • Figure 7: Respiratory Gas Monitors Market in the United States (2021-2030)
  • Figure 8: Respiratory Gas Monitors Market in Canada (2021-2030)
  • Figure 9: Respiratory Gas Monitors Market in Mexico (2021-2030)
  • Figure 10: Respiratory Gas Monitors Market in Europe (2021-2030)
  • Figure 11: Respiratory Gas Monitors Market in France (2021-2030)
  • Figure 12: Respiratory Gas Monitors Market in Germany (2021-2030)
  • Figure 13: Respiratory Gas Monitors Market in United Kingdom (2021-2030)
  • Figure 14: Respiratory Gas Monitors Market in Italy (2021-2030)
  • Figure 15: Respiratory Gas Monitors Market in Spain (2021-2030)
  • Figure 16: Respiratory Gas Monitors Market in the Rest of Europe (2021-2030)
  • Figure 17: Respiratory Gas Monitors Market in Asia-Pacific (2021-2030)
  • Figure 18: Respiratory Gas Monitors Market in China (2021-2030)
  • Figure 19: Respiratory Gas Monitors Market in Japan (2021-2030)
  • Figure 20: Respiratory Gas Monitors Market in India (2021-2030)
  • Figure 21: Respiratory Gas Monitors Market in Australia (2021-2030)
  • Figure 22: Respiratory Gas Monitors Market in South Korea (2021-2030)
  • Figure 23: Respiratory Gas Monitors Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Respiratory Gas Monitors Market in the Rest of the World (2021-2030)
  • Figure 25: Respiratory Gas Monitors Market in the Middle East (2021-2030)
  • Figure 26: Respiratory Gas Monitors Market in Africa (2021-2030)
  • Figure 27: Respiratory Gas Monitors Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Market Opportunities
  • Figure 31: PORTER'S Five Force Analysis